A 58-year-old man has undergone replacement of the ascending aorta in another hospital. A few months after surgery, the patient experienced pain in the lower limbs, shortness of breath, and ...

This new therapy potentially allows patients to avoid conventional surgery to repair aneurysms of the ascending aorta. The ARISE II Study is the first multicenter pivotal study approved by the U.S.

Considering all pathogeneses, ascending TAAs typically grow at 0.25 to 1 mm/y ... included symptomatic patients or patients scheduled to undergo aortic repair, or reported growth only after aortic ...

We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a look at where Edwards Lifesciences (NYSE:EW) stands against other stocks that ...

Aortic root or ascending aorta aneurysm 5.5 cm or rapid growth; with aortic valve replacement 5.0 cm Descending thoracic aorta: repair threshold in 5.5 cm (endovascular) and 6 cm (open) Nonsyndromic ...

The hemodynamic observations in the r-CoA were mainly: 1) increased vorticity at the site of CoA repair (no-CoA: 387 1/s vs. r-CoA: 711 1/s at location 0.5), Figure 5; 3) increased power loss (+22%) ...

In complicated Stanford Type B situations, thoracic endovascular aortic repair (TEVAR) is currently indicated ... ECG gating (for the study of the aortic root and ascending aorta), and fast ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...